Oxytocin Research Guide: Structure, Receptor Signaling and Stability
What oxytocin is (CYIQNCPLG-NH2), how the oxytocin receptor signals, how it differs from vasopressin, what published stability studies show, and what an oxytocin COA should include.
Oxytocin is a nine-residue cyclic peptide (CYIQNCPLG-NH2, about 1007.2 g/mol) that acts on the oxytocin receptor, a Gq-coupled GPCR. Oxytocin research spans receptor pharmacology, reproductive physiology and social-behaviour models. In the lab, its disulfide ring and deamidation-prone residues make identity testing by mass spectrometry and cold, dry storage especially important.
Oxytocin holds a special place in peptide chemistry. In 1953 Vincent du Vigneaud’s group reported the first laboratory synthesis of a peptide hormone with full biological activity — oxytocin — work recognised with the 1955 Nobel Prize in Chemistry. Seven decades later it remains one of the most widely studied neuropeptides, and also one of the most frequently misunderstood. This guide covers what the molecule is, how its receptor signals, how it differs from vasopressin, and what a researcher should check on an oxytocin certificate of analysis.
What is oxytocin?
Oxytocin is a cyclic nonapeptide hormone made mainly in the hypothalamus and released from the posterior pituitary. Its sequence is Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2. A disulfide bond between Cys1 and Cys6 closes a six-residue ring, and a three-residue tail (Pro-Leu-Gly-NH2) ends in an amidated C-terminus.
Gimpl and Fahrenholz’s 2001 review in Physiological Reviews remains a standard reference on the oxytocin receptor system, covering its classical roles in uterine contraction and milk ejection as well as receptor expression in brain, kidney, heart, bone and other tissues. Oxytocin is also an approved medicine in obstetrics, which is why its stability has been studied in such detail.
| Property | Value |
|---|---|
| Sequence | CYIQNCPLG-NH2 (disulfide Cys1–Cys6) |
| Molecular formula | C43H66N12O12S2 |
| Average molecular weight | ≈ 1007.2 g/mol |
| Monoisotopic mass (calculated) | ≈ 1006.44 Da |
| Expected ESI-MS ions | [M+H]+ ≈ m/z 1007.44; [M+2H]2+ ≈ m/z 504.23 |
| PubChem CID | 439302 |
| Receptor | Oxytocin receptor (OXTR), class A GPCR |
For background on how average and monoisotopic masses are derived, see our guide to peptide molecular weight and net peptide content.
How does the oxytocin receptor signal?
The oxytocin receptor (OXTR) is a seven-transmembrane G protein-coupled receptor that signals primarily through Gq/11, activating phospholipase C, generating IP3 and diacylglycerol, and raising intracellular calcium. Jurek and Neumann’s 2018 review describes how OXTR can also couple to other G proteins and engage downstream cascades such as MAPK and eEF2 pathways depending on cell type.
That signalling diversity is a large part of why oxytocin appears in so many research fields. The same receptor is studied in myometrial contraction assays, mammary myoepithelial cells, cardiovascular tissue and neuronal circuits, and the observed effect depends heavily on the tissue, receptor density and experimental model.
Oxytocin vs vasopressin: what is the difference?
Oxytocin and arginine vasopressin (AVP) differ at only two of nine positions, yet they act on largely distinct receptor families. Both share the Cys1–Cys6 ring and an amidated glycine tail.
| Feature | Oxytocin | Arginine vasopressin |
|---|---|---|
| Sequence | CYIQNCPLG-NH2 | CYFQNCPRG-NH2 |
| Position 3 | Isoleucine | Phenylalanine |
| Position 8 | Leucine | Arginine |
| Main receptor(s) | OXTR | V1a, V1b, V2 |
| Selectivity (Manning et al. 2012) | Selective for the human OT receptor | Binds V1a, V1b, V2 and OT receptors with similar affinities |
Manning and colleagues point out that vasopressin’s lack of selectivity may explain why some of its effects in vivo are mediated through oxytocin receptors. For experimental design, this means vasopressin contamination or receptor cross-talk is a real confound, and selective receptor antagonists are often used to attribute an effect to one receptor.
What does oxytocin research cover?
Published oxytocin research falls into a few broad areas, each with its own typical models:
- Receptor pharmacology — binding and functional assays in cells expressing OXTR or vasopressin receptors, and the design of selective agonists and antagonists.
- Reproductive physiology — uterine contraction and lactation models, the areas in which oxytocin’s function was first characterised.
- Social behaviour in animals — rodent and prairie vole studies of social recognition and pair bonding, which link OXTR distribution in specific brain regions to behaviour.
- Human experimental studies — mostly intranasal studies of social cognition, a literature that has faced significant methodological criticism (see below).
- Formulation science — work on heat-stable formulations and analogues such as carbetocin, driven by oxytocin’s need for cold-chain storage.
Why is the intranasal oxytocin literature debated?
Much of the human behavioural literature is underpowered. Walum, Waldman and Young (2016) estimated an average statistical power of about 16% for intranasal oxytocin studies in healthy participants and 12% for clinical trials, and calculated that under plausible assumptions the positive predictive value of a significant finding could be 24% or lower. Their conclusion was that many reported effects may be false positives.
Additional open questions include how much intact peptide reaches the brain after peripheral or intranasal delivery and how reliably oxytocin can be measured in plasma. Researchers reviewing this field generally give greater weight to well-powered, pre-registered and replicated work.
How stable is oxytocin, and how should it be stored?
Oxytocin is notably heat-sensitive in solution, and its degradation depends strongly on pH. Hawe et al. (2009) held 0.1 mg/mL oxytocin at pH 2.0, 4.5, 7.0 and 9.0 and at 40–80 °C. pH 4.5 was the most stable condition at every temperature, with a half-life of roughly 115 days at 40 °C, compared with about 7 days at pH 9.0 and 40 °C.
The degradation products they identified are useful to know when reading analytical data:
- Deamidation of Gln4, Asn5 and the C-terminal Gly9-NH2 (a +0.98 Da shift per site), dominant at pH 2.0.
- Tri- and tetrasulfides — extra sulfur inserted into the disulfide bridge (+32 Da per added sulfur), seen at pH 4.5, 7.0 and 9.0.
- Disulfide-linked dimers and larger aggregates, which appear at roughly twice the monomer mass.
- β-elimination products arising from the cystine residues.
The cold-chain problem has real-world consequences. In the WHO CHAMPION trial (Widmer et al., NEJM 2018), which randomised 29,645 women in 10 countries, oxytocin required refrigerated storage, whereas the heat-stable carbetocin formulation was reported stable for 36 months at 30 °C and 75% relative humidity.
For laboratory material, the practical points are standard: store lyophilized oxytocin cold (typically −20 °C), dry and away from light; let vials reach room temperature before opening to avoid condensation; aliquot solutions to avoid repeated freeze–thaw; and use solutions promptly. Our peptide storage and degradation guide and peptide solubility guide cover these steps in more depth.
What should an oxytocin COA show?
A useful oxytocin certificate of analysis should confirm identity by mass, report purity by HPLC, and make it possible to spot the degradation products above.
- Mass spectrometry identity — an observed mass matching ≈ 1007.2 (average) or ions near m/z 1007.4 [M+H]+ / 504.2 [M+2H]2+. Peaks at +1 Da, +32 Da or about double mass suggest deamidation, trisulfide or dimer.
- HPLC purity — reversed-phase chromatogram with the main peak percentage, wavelength and method stated.
- Lot traceability — a batch number matching the vial, plus test date and laboratory.
- Appearance — a white lyophilized cake or powder; see what a lyophilized cake should look like.
Our step-by-step guide on how to read a peptide COA explains each of these fields, and current batch reports are published on the Soraci Labs COA page. The Oxytocin 5mg research peptide listing links to its lot documentation.
Frequently asked questions
References
- du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc. 1953;75(19):4879–4880. doi:10.1021/ja01115a553. DOI
- Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629–683. doi:10.1152/physrev.2001.81.2.629. PMID 11274341. PubMed
- Jurek B, Neumann ID. The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev. 2018;98(3):1805–1908. doi:10.1152/physrev.00031.2017. PMID 29897293. PubMed
- Manning M, Misicka A, Olma A, et al. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol. 2012;24(4):609–628. doi:10.1111/j.1365-2826.2012.02303.x. PMID 22375852. PubMed
- Hawe A, Poole R, Romeijn S, Kasper P, van der Heijden R, Jiskoot W. Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products. Pharm Res. 2009;26(7):1679–1688. doi:10.1007/s11095-009-9878-2. DOI
- Walum H, Waldman ID, Young LJ. Statistical and methodological considerations for the interpretation of intranasal oxytocin studies. Biol Psychiatry. 2016;79(3):251–257. doi:10.1016/j.biopsych.2015.06.016. PMID 26210057. PubMed
- Widmer M, Piaggio G, Nguyen TMH, et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med. 2018;379(8):743–752. doi:10.1056/NEJMoa1805489. DOI
- PubChem. Oxytocin, CID 439302. National Center for Biotechnology Information. PubChem
All Soraci Labs products are sold for laboratory, analytical and research purposes only. They are not intended for human consumption, medical use, diagnostic use, or the treatment of any disease or condition.
